NCT01745601View on ClinicalTrials.gov

Bioequivalence Study of Escitalopram Tablets 10 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

May 4, 2010

Primary Completion Date

May 19, 2010

Study Completion Date

May 19, 2010

Conditions

Anxiety Disorders

Interventions

DRUG

escitalopram 10 mg

Reference product

DRUG

escitalopram 10 mg

Test product

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01745601 - Bioequivalence Study of Escitalopram Tablets 10 mg | Biotech Hunter | Biotech Hunter